Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Metformin Hydrochloride and Empagliflozin Tablets（Ⅰ）
- Product Name
- 二甲双胍恩格列净片(Ⅰ)
- Approval Number
- 国药准字H20254143
- Approval Date
- May 13, 2025
NMPA
Carbocysteine Oral Solution
- Product Name
- 羧甲司坦口服溶液
- Approval Number
- 国药准字H20253968
- Approval Date
- Apr 22, 2025
NMPA
Carbocysteine Oral Solution
- Product Name
- 羧甲司坦口服溶液
- Approval Number
- 国药准字H20253645
- Approval Date
- Mar 18, 2025
NMPA
Sitagliptin Phosphate and Metformin Hydrochloride Tablets(Ⅱ)
- Product Name
- 西格列汀二甲双胍片(Ⅱ)
- Approval Number
- 国药准字H20244159
- Approval Date
- Jun 25, 2024
NMPA
Sitagliptin Phosphate and Metformin Hydrochloride Tablets(Ⅰ)
- Product Name
- 西格列汀二甲双胍片(Ⅰ)
- Approval Number
- 国药准字H20244158
- Approval Date
- Jun 25, 2024
NMPA
Metformin Hydrochloride Extended-release Tablets
- Product Name
- 盐酸二甲双胍缓释片
- Approval Number
- 国药准字H20223245
- Approval Date
- Apr 19, 2022
NMPA
Clinical Trials
No trials found
News
No news found